Evidence map›Paper›PMID 32685122›Full record

ArticleIranian journal of microbiology2020

Immune response in cutaneous leishmaniasis patients with healing

Akram Miramin-Mohammadi, Amir Javadi, Seyed Ebrahim Eskandari, Hossein Mortazavi, Mahmoud Nateghi Rostami, Ali Khamesipour

Open access · diamondAbstract read
In one paragraph

Article in Iranian journal of microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Observational
  4. Advances inPathogens (Basel, Switzerland) · 2024
    Review
  5. The level of interleukin-17, 23, and gamma interferon in cutaneous leishmaniasis patients before and after intra lesion treatment.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Akram Miramin-MohammadiCenter for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
Amir JavadiDepartment of Social Medicines, Qazvin University of Medical Sciences, Qazvin, Iran.
Seyed Ebrahim EskandariCenter for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
Hossein MortazaviDepartment of Dermatology, Tehran University of Medical Sciences, Razi Hospital, Tehran, Iran.
Mahmoud Nateghi RostamiDepartment of Parasitology, Pasteur Institute of Iran, Tehran, Iran.
Ali KhamesipourCenter for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.
Tehran University of Medical Sciences · IRPasteur Institute of Iran · IRQazvin University of Medical Sciences · IRRazi Hospital · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe outcome of MATERIALS AND

methodsThis study was carried out in leishmaniasis clinic of CRTSDL, TUMS, during March 2018 to March 2019. Peripheral blood mononuclear cells (PBMC) of volunteers with active healing and non-healing lesion (s) of cutaneous leishmaniasis (CL), volunteers with and without history of CL were cultured and stimulated with Soluble

resultsThe results showed a significantly higher levels of IFN-γ in volunteers with active CL healing form (

conclusionIFN-γ production starts at early stage of cutaneous leishmaniasis and enhance during course of lesion healing, IFN-γ level is significantly higher in all patients compared to healthy volunteers, IFN-γ is significantly higher in patients with healing form than non-healing form of lesion.

Indexed as

Cutaneous leishmaniasisImmune responseInterferon gamma (IFNγ)Interleukin 10 (IL-10)Interleukin 5 (IL-5)Soluble Leishmania antigen (SLA)

Identifiers

PMID32685122
PMCPMC7340611
OpenAlexW3036473088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.